Compugroup Medical Se Stock Net Income
| CMPVF Stock | USD 29.89 0.00 0.00% |
CompuGroup Medical SE fundamentals help investors to digest information that contributes to CompuGroup Medical's financial success or failures. It also enables traders to predict the movement of CompuGroup Pink Sheet. The fundamental analysis module provides a way to measure CompuGroup Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CompuGroup Medical pink sheet.
CompuGroup |
CompuGroup Medical SE Company Net Income Analysis
CompuGroup Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current CompuGroup Medical Net Income | 68.97 M |
Most of CompuGroup Medical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CompuGroup Medical SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, CompuGroup Medical SE reported net income of 68.97 M. This is 79.79% lower than that of the sector and significantly higher than that of the Net Income industry. The net income for all United States stocks is 87.92% higher than that of the company.
CompuGroup Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CompuGroup Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CompuGroup Medical could also be used in its relative valuation, which is a method of valuing CompuGroup Medical by comparing valuation metrics of similar companies.CompuGroup Medical is currently under evaluation in net income category among related companies.
CompuGroup Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.89 B | |||
| Shares Outstanding | 52.23 M | |||
| Shares Owned By Insiders | 50.30 % | |||
| Shares Owned By Institutions | 29.69 % | |||
| Price To Earning | 20.14 X | |||
| Price To Book | 2.49 X | |||
| Price To Sales | 1.97 X | |||
| Revenue | 1.03 B | |||
| Gross Profit | 411.46 M | |||
| EBITDA | 213.99 M | |||
| Net Income | 68.97 M | |||
| Cash And Equivalents | 120.07 M | |||
| Cash Per Share | 2.30 X | |||
| Total Debt | 587.08 M | |||
| Debt To Equity | 1.32 % | |||
| Current Ratio | 0.87 X | |||
| Book Value Per Share | 12.87 X | |||
| Cash Flow From Operations | 165.27 M | |||
| Earnings Per Share | 1.49 X | |||
| Number Of Employees | 8.83 K | |||
| Beta | 1.07 | |||
| Market Capitalization | 2.39 B | |||
| Total Asset | 1.79 B | |||
| Z Score | 2.4 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 1.79 B |
About CompuGroup Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CompuGroup Medical SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CompuGroup Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CompuGroup Medical SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with CompuGroup Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CompuGroup Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CompuGroup Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with CompuGroup Pink Sheet
| 0.8 | AAPL | Apple Inc Report 2nd of May 2024 | PairCorr |
Moving against CompuGroup Pink Sheet
| 0.92 | XOM | Exxon Mobil Corp Sell-off Trend | PairCorr |
| 0.83 | AA | Alcoa Corp Financial Report 17th of July 2024 | PairCorr |
| 0.81 | AMZN | Amazon Inc Earnings Call This Week | PairCorr |
| 0.8 | CVX | Chevron Corp Report 26th of April 2024 | PairCorr |
| 0.79 | JPM | JPMorgan Chase Financial Report 12th of July 2024 | PairCorr |
The ability to find closely correlated positions to CompuGroup Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CompuGroup Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CompuGroup Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CompuGroup Medical SE to buy it.
The correlation of CompuGroup Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CompuGroup Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CompuGroup Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CompuGroup Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CompuGroup Medical SE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for CompuGroup Pink Sheet analysis
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |